Palivizumab is used to treat respiratory syncytial virus disease. This antiviral drug is a(n)
A) vaccine.
B) nucleoside analog.
C) toxoid.
D) immunosuppressive.
E) monoclonal antibody.

Question

Quizplus · Accepted Answer

Palivizumab is a monoclonal antibody that is used to prevent respiratory syncytial virus (RSV) disease in high-risk infants and young children. It works by binding to a specific protein on the RSV virus and preventing it from invading and infecting cells. This helps to reduce the severity of RSV infections and prevent hospitalizations in high-risk patients.

Palivizumab Is Used to Treat Respiratory Syncytial Virus Disease